BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eltahir HM, Nazmy MH. Esomeprazole ameliorates CCl4 induced liver fibrosis in rats via modulating oxidative stress, inflammatory, fibrogenic and apoptotic markers. Biomed Pharmacother 2018;97:1356-65. [PMID: 29156525 DOI: 10.1016/j.biopha.2017.11.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Hafez DA, Abdelmonsif DA, Aly RG, Samy WM, Elkhodairy KA, Abo Aasy NK. Role of fennel oil/ quercetin dual nano-phytopharmaceuticals in hampering liver fibrosis: Comprehensive optimization and in vivo assessment. Journal of Drug Delivery Science and Technology 2022;69:103177. [DOI: 10.1016/j.jddst.2022.103177] [Reference Citation Analysis]
2 Boushra AF, Elsayed AM, Ibrahim NA, Abdelwahed MK, Ahmed EI. A comparative study on the possible protective effect of esomeprazole, spirulina, wheatgrass on indomethacin-induced gastric ulcer in male albino rats. Mol Biol Rep 2019;46:4843-60. [PMID: 31297714 DOI: 10.1007/s11033-019-04933-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Hiromoto S, Kawashiri T, Yamanaka N, Kobayashi D, Mine K, Inoue M, Uchida M, Shimazoe T. Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome. Sci Rep 2021;11:8964. [PMID: 33903667 DOI: 10.1038/s41598-021-88460-9] [Reference Citation Analysis]
4 Shaban NZ, Yehia SA, Awad D, Shaban SY, Saleh SR. A Titanium (IV)-Dithiophenolate Complex and Its Chitosan Nanocomposite: Their Roles towards Rat Liver Injuries In Vivo and against Human Liver Cancer Cell Lines. Int J Mol Sci 2021;22:11219. [PMID: 34681878 DOI: 10.3390/ijms222011219] [Reference Citation Analysis]
5 Buzás GM. Helicobacter pylori and non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol 2020;66:267-79. [PMID: 32724031 DOI: 10.23736/S1121-421X.20.02671-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Gao Y, Xi B, Li J, Li Z, Xu J, Zhong M, Xu Q, Lian Y, Wei R, Wang L, Cao H, Jin L, Zhang K, Dong J. Scoparone alleviates hepatic fibrosis by inhibiting the TLR-4/NF-κB pathway. J Cell Physiol 2020. [PMID: 33090488 DOI: 10.1002/jcp.30083] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lu ZN, Niu WX, Zhang N, Ge MX, Bao YY, Ren Y, Guo XL, He HW. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation. Acta Pharmacol Sin 2021;42:1808-20. [PMID: 34465912 DOI: 10.1038/s41401-021-00754-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
8 Ghebre YT. Proton Pump Inhibitors and Osteoporosis: Is Collagen a Direct Target? Front Endocrinol (Lausanne) 2020;11:473. [PMID: 32793122 DOI: 10.3389/fendo.2020.00473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
9 Liu J, Pi Z, Xiao Y, Zeng Z, Yu J, Zou P, Tang B, Qiu X, Tang R, Shi Y, Xiao R. Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling. Pharmacol Res 2022;176:106057. [PMID: 34995795 DOI: 10.1016/j.phrs.2022.106057] [Reference Citation Analysis]
10 Song X, Cui W, Gao Z, Zhang J, Jia L. Structural characterization and amelioration of sulfated polysaccharides from Ganoderma applanatum residue against CCl4-induced hepatotoxicity. Int Immunopharmacol 2021;96:107554. [PMID: 33812257 DOI: 10.1016/j.intimp.2021.107554] [Reference Citation Analysis]
11 Slama K, Boumendjel M, Taibi F, Boumendjel A, Messarah M. Atriplex halimus aqueous extract abrogates carbon tetrachloride-induced hepatotoxicity by modulating biochemical and histological changes in rats. Arch Physiol Biochem 2020;126:49-60. [PMID: 30269598 DOI: 10.1080/13813455.2018.1489852] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Hammond CL, Roztocil E, Phipps RP, Feldon SE, Woeller CF. Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor. PLoS One 2019;14:e0222779. [PMID: 31536596 DOI: 10.1371/journal.pone.0222779] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chen Y, Zhou Z, Mo Q, Zhou G, Wang Y. Gallic Acid Attenuates Dimethylnitrosamine-Induced Liver Fibrosis by Alteration of Smad Phosphoisoform Signaling in Rats. Biomed Res Int 2018;2018:1682743. [PMID: 30627538 DOI: 10.1155/2018/1682743] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Shaban NZ, Aboelsaad AM, Awad D, Abdulmalek SA, Shaban SY. Therapeutic effect of dithiophenolato chitosan nanocomposites against carbon tetrachloride-induced hepatotoxicity in rats. Environ Sci Pollut Res Int 2021. [PMID: 34487322 DOI: 10.1007/s11356-021-15834-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gao Z, Yuan F, Li H, Feng Y, Zhang Y, Zhang C, Zhang J, Song Z, Jia L. The ameliorations of Ganoderma applanatum residue polysaccharides against CCl4 induced liver injury. Int J Biol Macromol 2019;137:1130-40. [PMID: 31295484 DOI: 10.1016/j.ijbiomac.2019.07.044] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
16 Ghebre YT. Proton Pump Inhibitors in IPF: A Call for Clinical Trials. Front Pharmacol 2018;9:499. [PMID: 29867501 DOI: 10.3389/fphar.2018.00499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]